Furthermore, β-catenin/TCF complex target genes (ZEB1, CyclinD1 and c-Myc,) which were increased by doxorubicin, were downregulated following the disruption of β-catenin/TCF4 interaction in HCC cells (Fig. 4B). Here, MYC is linked to hepatocellular carcinoma.